Soligenix COVID-19 Vaccine CiVax Program Presentation

Soligenix presents its COVID-19 vaccine development strategy, including the CiVax program and Dusquetide therapeutic candidate. The presentation covers corporate overview, vaccine market landscape, and clinical applications led by President & CEO Dr. Christopher Schaber and Chief Scientific Officer Dr. Oreola Donini.